Pharmabiz carries and editorial,
India offers a unique opportunity for conducting clinical trials with a large and diverse patient pool along with considerable low trial costs. The acceptability of Indian pharmaceutical industry as a reliable source for these services will, however, depend on the quality of services provided by the companies. And it is here the Indian pharmaceutical industry and the regulatory bodies have to be extremely vigilant.
Give schedule Y of clinical trial
Difference between ICH GCP & Indian GCP
Can u provide any information about revised shedule Y and Indian CRO practices?
hi friend …
now i am doing P.G.Diploma in clinical research and datamanagement. i have intrest to work as a CRA in your organization. if any opening in CRA please mail me.
thanks & regards